BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35715917)

  • 1. Circulating Abnormal Extracellular Vesicles: Their Mechanism for Crossing Blood-Brain Barrier, Effects on Central Nervous System and Detection Methods.
    Fan B; Gu J; Wu J; Sun Y; Huang R; Shen H; Zhang X; Li Z
    J Biomed Nanotechnol; 2022 Mar; 18(3):640-659. PubMed ID: 35715917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
    Matsumoto J; Stewart T; Banks WA; Zhang J
    Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.
    Saint-Pol J; Gosselet F; Duban-Deweer S; Pottiez G; Karamanos Y
    Cells; 2020 Apr; 9(4):. PubMed ID: 32244730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders.
    Wang D; Guan S; Lu P; Li Y; Xu H
    Biomed Pharmacother; 2023 Apr; 160():114354. PubMed ID: 36753954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of claudin-5
    Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
    J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
    Ramirez SH; Andrews AM; Paul D; Pachter JS
    Fluids Barriers CNS; 2018 Jul; 15(1):19. PubMed ID: 29960602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood-Brain Barrier System.
    Fikatas A; Dehairs J; Noppen S; Doijen J; Vanderhoydonc F; Meyen E; Swinnen JV; Pannecouque C; Schols D
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles as contributors in the pathogenesis of multiple sclerosis.
    Zamboni S; D'Ambrosio A; Margutti P
    Mult Scler Relat Disord; 2023 Mar; 71():104554. PubMed ID: 36842311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances on Extracellular Vesicles in Central Nervous System Diseases.
    Jin T; Gu J; Li Z; Xu Z; Gui Y
    Clin Interv Aging; 2021; 16():257-274. PubMed ID: 33603351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles at CNS barriers: Mode of action.
    Krämer-Albers EM
    Curr Opin Neurobiol; 2022 Aug; 75():102569. PubMed ID: 35667340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of exosomes in central nervous system tissue regeneration and repair.
    Wang J; Yang L
    Biomed Mater; 2023 Jul; 18(5):. PubMed ID: 37399812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges.
    Dutta S; Hornung S; Taha HB; Bitan G
    Acta Neuropathol; 2023 May; 145(5):515-540. PubMed ID: 37012443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered EVs designed to target diseases of the CNS.
    Nieland L; Mahjoum S; Grandell E; Breyne K; Breakefield XO
    J Control Release; 2023 Apr; 356():493-506. PubMed ID: 36907561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles through the blood-brain barrier: a review.
    Ramos-Zaldívar HM; Polakovicova I; Salas-Huenuleo E; Corvalán AH; Kogan MJ; Yefi CP; Andia ME
    Fluids Barriers CNS; 2022 Jul; 19(1):60. PubMed ID: 35879759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier
    Morad G; Carman CV; Hagedorn EJ; Perlin JR; Zon LI; Mustafaoglu N; Park TE; Ingber DE; Daisy CC; Moses MA
    ACS Nano; 2019 Dec; 13(12):13853-13865. PubMed ID: 31479239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of the erythrocyte miR-451a in brain extracellular vesicles following impairment of the blood-brain barrier.
    Koopaei NN; Chowdhury EA; Jiang J; Noorani B; da Silva L; Bulut G; Hakimjavadi H; Chamala S; Bickel U; Schmittgen TD
    Neurosci Lett; 2021 Apr; 751():135829. PubMed ID: 33727125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progression in application of extracellular vesicles in central nervous system diseases.
    Zhang XM; Huang J; Ni XY; Zhu HR; Huang ZX; Ding S; Yang XY; Tan YD; Chen JF; Cai JH
    Eur J Med Res; 2024 Jan; 29(1):15. PubMed ID: 38173021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.